These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 22887867)

  • 21. Marijuana-based drugs: innovative therapeutics or designer drugs of abuse?
    Seely KA; Prather PL; James LP; Moran JH
    Mol Interv; 2011 Feb; 11(1):36-51. PubMed ID: 21441120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prenatal exposure to cannabinoids evokes long-lasting functional alterations by targeting CB1 receptors on developing cortical neurons.
    de Salas-Quiroga A; Díaz-Alonso J; García-Rincón D; Remmers F; Vega D; Gómez-Cañas M; Lutz B; Guzmán M; Galve-Roperh I
    Proc Natl Acad Sci U S A; 2015 Nov; 112(44):13693-8. PubMed ID: 26460022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered motor development following late gestational alcohol and cannabinoid exposure in rats.
    Breit KR; Zamudio B; Thomas JD
    Neurotoxicol Teratol; 2019; 73():31-41. PubMed ID: 30943441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prenatal cannabinoid and gene expression for neural adhesion molecule L1 in the fetal rat brain.
    Gómez M; Hernández M; Johansson B; de Miguel R; Ramos JA; Fernández-Ruiz J
    Brain Res Dev Brain Res; 2003 Dec; 147(1-2):201-7. PubMed ID: 15068010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabis use during pregnancy: Pharmacokinetics and effects on child development.
    Grant KS; Petroff R; Isoherranen N; Stella N; Burbacher TM
    Pharmacol Ther; 2018 Feb; 182():133-151. PubMed ID: 28847562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tripping with Synthetic Cannabinoids ("Spice"): Anecdotal and Experimental Observations in Animals and Man.
    Järbe TUC; Raghav JG
    Curr Top Behav Neurosci; 2017; 32():263-281. PubMed ID: 27753006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabinoid modulation of drug reward and the implications of marijuana legalization.
    Covey DP; Wenzel JM; Cheer JF
    Brain Res; 2015 Dec; 1628(Pt A):233-43. PubMed ID: 25463025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phytocannabinoids, CNS cells and development: a dead issue?
    Downer EJ; Campbell VA
    Drug Alcohol Rev; 2010 Jan; 29(1):91-8. PubMed ID: 20078688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychological Functioning of Women Taking Illicit Drugs during Pregnancy and the Growth and Development of Their Offspring in Early Childhood.
    Serino Ma D; Peterson Md BS; Rosen Md TS
    J Dual Diagn; 2018; 14(3):158-170. PubMed ID: 29694295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prenatal cannabis exposure - The "first hit" to the endocannabinoid system.
    Richardson KA; Hester AK; McLemore GL
    Neurotoxicol Teratol; 2016; 58():5-14. PubMed ID: 27567698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Marijuana use in pregnancy and lactation: a review of the evidence.
    Metz TD; Stickrath EH
    Am J Obstet Gynecol; 2015 Dec; 213(6):761-78. PubMed ID: 25986032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prenatal cannabinoid exposure: why expecting individuals should take a pregnancy pause from using cannabinoid products.
    Lin A; Dent GL; Davies S; Dominguez ZM; Cioffredi LA; McLemore GL; Maxwell JR
    Front Pediatr; 2023; 11():1278227. PubMed ID: 37886232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential physiological and behavioral cues observed in individuals smoking botanical marijuana versus synthetic cannabinoid drugs.
    Chase PB; Hawkins J; Mosier J; Jimenez E; Boesen K; Logan BK; Walter FG
    Clin Toxicol (Phila); 2016; 54(1):14-9. PubMed ID: 26653952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models.
    Malone DT; Hill MN; Rubino T
    Br J Pharmacol; 2010 Jun; 160(3):511-22. PubMed ID: 20590561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Marijuana Use in Pregnancy: A Review.
    Thompson R; DeJong K; Lo J
    Obstet Gynecol Surv; 2019 Jul; 74(7):415-428. PubMed ID: 31343707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistent inhibitory circuit defects and disrupted social behaviour following in utero exogenous cannabinoid exposure.
    Vargish GA; Pelkey KA; Yuan X; Chittajallu R; Collins D; Fang C; McBain CJ
    Mol Psychiatry; 2017 Jan; 22(1):56-67. PubMed ID: 26976041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-lasting alterations of hippocampal GABAergic neurotransmission in adult rats following perinatal Δ
    Beggiato S; Borelli AC; Tomasini MC; Morgano L; Antonelli T; Tanganelli S; Cuomo V; Ferraro L
    Neurobiol Learn Mem; 2017 Mar; 139():135-143. PubMed ID: 28104530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behavioral pharmacology of cannabinoids with a focus on preclinical models for studying reinforcing and dependence-producing properties.
    Panagis G; Vlachou S; Nomikos GG
    Curr Drug Abuse Rev; 2008 Nov; 1(3):350-74. PubMed ID: 19630731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cannabis: Effects in the Central Nervous System. Therapeutic, societal and legal consequences].
    Rivera-Olmos VM; Parra-Bernal MC
    Rev Med Inst Mex Seguro Soc; 2016; 54(5):626-34. PubMed ID: 27428345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Behavioural consequences of maternal exposure to natural cannabinoids in rats.
    Navarro M; Rubio P; de Fonseca FR
    Psychopharmacology (Berl); 1995 Nov; 122(1):1-14. PubMed ID: 8711059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.